aspirin has been researched along with probucol in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.09) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Carbonneau, MA; Cartron, E; Descomps, B; Fouret, G; Léger, CL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Achmad, TH; Rao, GS | 1 |
| Fragoso, M; Guthrie, C; Hsiang, Y; Kao, J; Kopchok, GE; Peng, SK; Rosenbaum, D; White, RA; Zhen, EZ | 1 |
| Dostert, P; Hartmann, R; Oesch, F; Schladt, L; Strolin-Benedetti, M; Timms, C; Wörner, W | 1 |
| Hanioka, N; Kawashima, Y; Kozuka, H; Matsumura, M | 1 |
| Gil, MJ; Monreal, JI; Rivero, A | 1 |
| Andria, G; Catalano, I; Ciabattoni, G; Cirillo, F; Davì, G; Di Minno, G; Grandone, E; Margaglione, M; Patrono, C; Strisciuglio, P | 1 |
| Cleland, JG; Krikler, DM | 1 |
| Campagnola, M; Cominacini, L; Davoli, A; Garbin, U; Lo Cascio, V; Pasini, AF; Pastorino, AM; Rigoni, A; Sawamura, T | 1 |
| Cha, KS; Han, JY; Kim, HJ; Kim, JS; Kim, MH | 1 |
| Gejyo, F; In, H; Ito, S; Izumi, J; Kanazawa, M; Nakano, M; Ohno, T; Tanaka, H; Ueno, M; Wada, Y; Yahata, K | 1 |
| Alerci, M; Amann-Vesti, B; Aschwanden, M; Baumgartner, I; Bernier, J; Canevascini, R; Cozzi, L; Do, DD; Gallino, A; Greiner, R; Jacob, AL; Jäger, K; Kann, R; Kellner, F; Mahler, F; Schneider, E; Segatto, JM; Studer, G; Triller, J; Tutta, P | 1 |
| Geng, L; Li, ZX; Meng, XP; Wang, SX; Yin, CY; Zhang, JC | 1 |
| Lan, XH; Li, X; Xu, R; Zhou, YG | 1 |
| Hattori, H; Ishihara, M; Nagata, M; Takase, B; Tanaka, Y | 1 |
| Ahn, SH; Heo, SH; Hong, KS; Hwang, YH; Jung, JM; Kang, DW; Kim, BJ; Kim, YJ; Kwon, JH; Kwon, SU; Lee, EJ; Lee, J; Lee, JH; Lee, JS; Navarro, JC; Park, JH; Park, JM; Rha, JH; Seo, WK; Sohn, SI; Wong, LKS; Yu, S | 1 |
| Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF | 1 |
2 review(s) available for aspirin and probucol
| Article | Year |
|---|---|
Modification of atherosclerosis by agents that do not lower cholesterol.
Topics: Animals; Antioxidants; Arteriosclerosis; Aspirin; Calcium Channel Blockers; Fibrinolytic Agents; Heparin; Humans; Probucol; Rabbits; Vitamins; Warfarin | 1993 |
Pharmacological interventions for asymptomatic carotid stenosis.
Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; Humans; Ischemic Stroke; Metoprolol; Pravastatin; Probucol; Rosuvastatin Calcium; Stroke; Warfarin | 2023 |
6 trial(s) available for aspirin and probucol
| Article | Year |
|---|---|
Stenosis following laser thermal angioplasty--a blinded controlled randomized study between aspirin against Probucol.
Topics: Angioplasty, Laser; Animals; Aorta; Arteriosclerosis; Aspirin; Constriction, Pathologic; Female; Hot Temperature; Iliac Artery; Probucol; Rabbits | 1991 |
Effect of antioxidant probucol for preventing stent restenosis.
Topics: Aged; Antioxidants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Postoperative Complications; Probucol; Stents; Ticlopidine; Time Factors | 2002 |
Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Brachytherapy; Female; Femoral Artery; Follow-Up Studies; Humans; Intermittent Claudication; Male; Popliteal Artery; Probability; Probucol; Recurrence; Reference Values; Risk Assessment; Single-Blind Method; Treatment Outcome; Vascular Patency | 2004 |
[Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis].
Topics: Aged; Aspirin; Atherosclerosis; Atorvastatin; Cholesterol, HDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hypolipidemic Agents; Lipoproteins, LDL; Male; Matrix Metalloproteinase 9; Middle Aged; Probucol; Pyrroles | 2009 |
Combined therapeutic effect of probucol and cilostazol on endothelial function in patients with silent cerebral lacunar infarcts and hypercholesterolemia: a preliminary study.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Agents; Cholinergic Antagonists; Cilostazol; Drug Therapy, Combination; Endothelium, Vascular; Female; Health Behavior; Hemodynamics; Humans; Hypercholesterolemia; Life Style; Lipids; Male; Middle Aged; Platelet Aggregation Inhibitors; Probucol; Prospective Studies; Stroke, Lacunar; Tetrazoles; Vasodilation | 2014 |
Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
Topics: Aged; Antioxidants; Asian People; Aspirin; Brain Ischemia; Cardiovascular Diseases; Cerebral Hemorrhage; China; Cilostazol; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Philippines; Probucol; Republic of Korea; Stroke; Treatment Outcome | 2018 |
14 other study(ies) available for aspirin and probucol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Specific antioxidant activity of caffeoyl derivatives and other natural phenolic compounds: LDL protection against oxidation and decrease in the proinflammatory lysophosphatidylcholine production.
Topics: Antioxidants; Caffeic Acids; Humans; Inflammation Mediators; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phenols | 2001 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers.
Topics: Aspirin; Calcium Channel Blockers; Chemotaxis, Leukocyte; Diltiazem; Dose-Response Relationship, Drug; Endothelins; Humans; In Vitro Techniques; Indomethacin; Kinetics; Monocytes; Neomycin; Nifedipine; Probucol; Thioctic Acid; Verapamil | 1992 |
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Topics: Animals; Aspirin; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; Epoxide Hydrolases; Fatty Alcohols; Fenofibrate; Hepatomegaly; Hypolipidemic Agents; Imidazoles; Liver; Male; Microbodies; Microsomes, Liver; Oxidation-Reduction; Palmitoyl-CoA Hydrolase; Probucol; Rats; Rats, Inbred F344 | 1987 |
Induction of microsomal stearoyl-CoA desaturation by the administration of various peroxisome proliferators.
Topics: Adipates; Animals; Aspirin; Clofibric Acid; Dibutyl Phthalate; Diethylhexyl Phthalate; Enzyme Induction; Fatty Acid Desaturases; Lipids; Male; Microbodies; Microsomes, Liver; Organoids; Probucol; Rats; Rats, Inbred Strains; Stearoyl-CoA Desaturase | 1983 |
Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
Topics: Acetyl-CoA C-Acetyltransferase; Acyl-CoA Oxidase; Animals; Anti-Inflammatory Agents; Aspirin; Base Sequence; Brain; Catalase; Clofibrate; Diflunisal; Hypolipidemic Agents; Lipid Peroxidation; Liver; Male; Microbodies; Molecular Sequence Data; Oxidative Stress; Oxidoreductases; Probucol; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Zinc | 1994 |
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
Topics: Adolescent; Adult; Aspirin; Blood Coagulation; Blood Platelets; Child; Female; Fibrinolysis; Homocystinuria; Homozygote; Humans; Male; Platelet Aggregation; Probucol; Thromboxanes | 1993 |
The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide.
Topics: Allopurinol; Animals; Antibodies, Monoclonal; Antioxidants; Aorta; Ascorbic Acid; Aspirin; Bradykinin; Catecholamines; Cattle; Cells, Cultured; CHO Cells; Chromans; Cricetinae; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Flow Cytometry; Free Radical Scavengers; Hemostatics; Humans; Imidazolines; Lipoproteins, LDL; Mice; Nitric Oxide; omega-N-Methylarginine; Oxygen; Probucol; Protein Binding; Reactive Oxygen Species; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Superoxides; Thrombin; Time Factors | 2001 |
Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report.
Topics: Antibodies, Antineutrophil Cytoplasmic; Arteriosclerosis; Aspirin; Autoantibodies; Cholesterol, LDL; Female; Granulomatosis with Polyangiitis; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Mixed Connective Tissue Disease; Myeloblastin; Prednisolone; Probucol; Serine Endopeptidases; Treatment Outcome; Valproic Acid | 2004 |
[Effects of three different treatments on atherosclerosis and adipose in rats].
Topics: Adipose Tissue; Animals; Aspirin; Atherosclerosis; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Lovastatin; Male; Probucol; Rats; Rats, Sprague-Dawley | 2012 |